Business Context and Reporting Period
This Form 8-K Current Report was filed by CareDx, Inc. on March 11, 2021. The filing primarily addresses Item 5.02 regarding the appointment of a new Chief Financial Officer and Item 8.01 regarding the issuance of a related press release.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics, as this report focuses on executive compensation and appointments rather than financial performance results.
Material Changes
The material change reported is the appointment of Ankur Dhingra as Chief Financial Officer, effective March 25, 2021. Upon his appointment, Marcel Konrad will resume his role as Vice President, Corporate Controller, ending his tenure as Interim Chief Financial Officer.
Management Commentary and Compensation Details
Mr. Dhingra brings 18 years of experience from Agilent Technologies, Inc. His compensation package includes:
- Base Salary: $400,000 annualized.
- Performance Bonus: Eligible for up to 60% of base salary for fiscal year 2021.
- Equity Grants:
- 30,000 stock options (vesting 25% after one year, then monthly).
- 14,500 Restricted Stock Units (RSUs) (vesting 25% after one year, then annually).
- 2,500 Performance Restricted Stock Units (PRSUs) (vesting 50% at two years, 50% at three years).
Employment is on an "at-will" basis. The filing also notes the execution of standard change of control and indemnification agreements.
Investor Verification Checklist
- Verify the effective date of the CFO transition (March 25, 2021) and the immediate resumption of duties by the former Interim CFO.
- Review the full text of the Offer Letter (Exhibit 10.1) for specific performance metrics tied to the PRSUs and bonus structure.
- Confirm the vesting schedules for the 30,000 options and 14,500 RSUs to assess potential dilution and retention incentives.
- Check for any subsequent filings regarding the departure of Marcel Konrad or changes to the compensation committee's discretion.